Ruth Zeidman

Ruth has 13+ years of experience in strategic market access consulting. She advises clients with responsibilities for pharmaceutical, medical device, digital and combination products from early development to launch and throughout the life cycle to loss of exclusivity and beyond. Ruth has a particular focus on strategic value demonstration and the evidence supporting it, and as such, leads Putnam’s Strategic Value offering. She leads and oversees a wide range of market access strategy and multifunctional projects (that in addition to value and evidence generation planning also includes activities such as willingness to pay/pricing, landscape assessments, value communication), ensuring a consistent strategy that addresses clients’ objectives. She has experience across many therapy areas covering chronic, common, and rare conditions.

Prior to her career in market access, Ruth held academic research positions at University of California, San Francisco, and Imperial College London. Ruth has a PhD in molecular medicine and MSc in molecular biology, both from Lund University in Sweden.